These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 36980680)

  • 21. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway.
    Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
    J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of syndecans in disease and wound healing.
    Fears CY; Woods A
    Matrix Biol; 2006 Sep; 25(7):443-56. PubMed ID: 16934444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Syndecans in tumor cell adhesion and signaling.
    Beauvais DM; Rapraeger AC
    Reprod Biol Endocrinol; 2004 Jan; 2():3. PubMed ID: 14711376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen receptor beta modulates breast cancer cells functional properties, signaling and expression of matrix molecules.
    Piperigkou Z; Bouris P; Onisto M; Franchi M; Kletsas D; Theocharis AD; Karamanos NK
    Matrix Biol; 2016 Dec; 56():4-23. PubMed ID: 27179695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
    Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
    Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential Impact of Membrane-Bound and Soluble Forms of the Prognostic Marker Syndecan-1 on the Invasiveness, Migration, Apoptosis, and Proliferation of Cervical Cancer Cells.
    Hilgers K; Ibrahim SA; Kiesel L; Greve B; Espinoza-Sánchez NA; Götte M
    Front Oncol; 2022; 12():803899. PubMed ID: 35155241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.
    Mierke CT
    Rep Prog Phys; 2019 Jun; 82(6):064602. PubMed ID: 30947151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Follistatin-related protein 1 interacting partner of Syndecan-1 promotes an aggressive phenotype on Oral Squamous cell carcinoma (OSCC) models.
    Zandonadi FS; Yokoo S; Granato DC; Rivera C; Macedo CCS; Soares CD; Carnielli CM; Domingues RR; Pauletti BA; Consonni SR; Colleta RD; Paes Leme AF
    J Proteomics; 2022 Mar; 254():104474. PubMed ID: 34990821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Syndecan-1 Facilitates the Human Mesenchymal Stem Cell Osteo-Adipogenic Balance.
    Yu C; Peall IW; Pham SH; Okolicsanyi RK; Griffiths LR; Haupt LM
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
    Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
    Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
    [No Abstract]   [Full Text] [Related]  

  • 31. Syndecans in heart fibrosis.
    Lunde IG; Herum KM; Carlson CC; Christensen G
    Cell Tissue Res; 2016 Sep; 365(3):539-52. PubMed ID: 27411689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific structural features of syndecans and heparan sulfate chains are needed for cell signaling.
    Lopes CC; Dietrich CP; Nader HB
    Braz J Med Biol Res; 2006 Feb; 39(2):157-67. PubMed ID: 16470302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
    Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
    J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparan Sulfate Proteoglycans May Promote or Inhibit Cancer Progression by Interacting with Integrins and Affecting Cell Migration.
    Soares MA; Teixeira FC; Fontes M; Arêas AL; Leal MG; Pavão MS; Stelling MP
    Biomed Res Int; 2015; 2015():453801. PubMed ID: 26558271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting.
    Theocharis AD; Skandalis SS; Tzanakakis GN; Karamanos NK
    FEBS J; 2010 Oct; 277(19):3904-23. PubMed ID: 20840587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights into the key roles of proteoglycans in breast cancer biology and translational medicine.
    Theocharis AD; Skandalis SS; Neill T; Multhaupt HA; Hubo M; Frey H; Gopal S; Gomes A; Afratis N; Lim HC; Couchman JR; Filmus J; Sanderson RD; Schaefer L; Iozzo RV; Karamanos NK
    Biochim Biophys Acta; 2015 Apr; 1855(2):276-300. PubMed ID: 25829250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours.
    Mennerich D; Vogel A; Klaman I; Dahl E; Lichtner RB; Rosenthal A; Pohlenz HD; Thierauch KH; Sommer A
    Eur J Cancer; 2004 Jun; 40(9):1373-82. PubMed ID: 15177497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNAs regulate the epithelial-mesenchymal transition and influence breast cancer invasion and metastasis.
    Zhao M; Ang L; Huang J; Wang J
    Tumour Biol; 2017 Feb; 39(2):1010428317691682. PubMed ID: 28222665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Syndecan-1 (CD138) as a Pathogenesis Factor and Therapeutic Target in Breast Cancer.
    Sheta M; Götte M
    Curr Med Chem; 2021; 28(25):5066-5083. PubMed ID: 34191695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.